.
6160 financial statements
* Numbers in millions
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
Capitalization * |
54 381 | 70 575 | 148 411 | 86 111 |
EV * |
53 866 | 70 209 | 147 562 | 147 562 |
Stock price ¤ |
75.45 | 90.4 | 190.1 | 110.3 |
Number of shares * |
721 | 781 | 781 | 781 |
EPS |
-0,93 | -1,22 | -2,05 | -2,05 |
Revenue * |
198 | 428 | 309 | 309 |
Net income * |
-674 | -949 | -1 597 | -1 597 |
Operating profit * |
-706 | -960 | -1 658 | -1 658 |
Total liabilities * |
496 | 634 | 1 732 | 1 732 |
Net debt * |
-515 | -367 | -849 | -849 |
Total assets * |
2 250 | 1 612 | 5 601 | 5 601 |
Equity * |
1 739 | 962 | 3 869 | 3 869 |
Cash and investments * |
1 781 | 983 | 4 651 | 4 651 |
Over the past 10 years, the maximum capitalization of BeiGene, Ltd. is 148 411, the minimum is 54 381. Maximum net income 0, Minimum net income -1 597. The maximum price of 6160 shares is 190.1, the minimum price is 75.45.
.
6160 valuation
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
P/E |
-80,71 | -74,40 | -92,94 | -53,92 |
P/B |
31,27 | 73,35 | 38,36 | 22,26 |
P/S |
274,35 | 164,81 | 480,49 | 278,79 |
E/P |
-1% | -1% | -1% | -2% |
P/FCF |
-78,98 | -77,65 | -98,12 | -56,93 |
.
6160 profitability
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
ROE |
-39% | -99% | -41% | |
ROA |
-31% | -59% | -29% | |
ROIC |
-35% | -74% | -37% |